We are live on ! Find out more
CHTP

CHELSEA THERAPEUTICS INT'L LTD
CHTP

Delisted

CHTP was delisted on the 23rd of June, 2014.

85 hedge funds and large institutions have $204M invested in CHELSEA THERAPEUTICS INT'L LTD in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

86% more call options, than puts

Call options by funds: $13.4M | Put options by funds: $7.2M

59% more capital invested

Capital invested by funds: $128M → $204M (+$75.8M)

41% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 17

12% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 25

9% more funds holding

Funds holding: 7885 (+7)

Holders
85
Holders Change
+7
Holders Change %
+8.97%
% of All Funds
2.45%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
24
Increased
28
Reduced
25
Closed
17
Calls
$13.4M
Puts
$7.2M
Net Calls
+$6.18M
Net Calls Change
+$3.58M
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
51
Morgan Stanley
New York
$270K +$26.4K +5,267 +12%
PAM
52
Panagora Asset Management
Massachusetts
$254K -$522K -103,954 -69%
Bank of America
53
Bank of America
North Carolina
$216K +$170K +33,849 +651%
Renaissance Technologies
54
Renaissance Technologies
New York
$184K -$3.43M -683,188 -95%
SG Americas Securities
55
SG Americas Securities
New York
$153K +$139K +27,732 New
AGM
56
Alpine Global Management
New York
$144K +$130K +26,000 New
VKH
57
Virtu KCG Holdings
New York
$142K -$80.5K -16,033 -38%
PAAMCP
58
Pacific Alternative Asset Management Company (PAAMCO)
California
$141K +$128K +25,536 New
MLICM
59
Metropolitan Life Insurance Company (MetLife)
New York
$139K
FMA
60
FNY Managed Accounts
New York
$138K +$125K +25,000 New
ID
61
Integral Derivatives
New York
$137K +$124K +24,790 New
Nomura Holdings
62
Nomura Holdings
Japan
$127K -$88.2K -17,567 -44%
Tudor Investment Corp
63
Tudor Investment Corp
Connecticut
$112K -$2.66K -530 -3%
Citigroup
64
Citigroup
New York
$105K -$188K -37,370 -66%
Connor, Clark & Lunn Investment Management (CC&L)
65
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$82K +$67.3K +13,400 New
JG
66
Jefferies Group
New York
$79K +$72.3K +14,400 New
QIM
67
Quantitative Investment Management
Virginia
$77K +$70.8K +14,100 New
TAM
68
Telluride Asset Management
Minnesota
$70K +$64K +12,747 New
GA
69
Gateway Advisory
New Jersey
$69K
Bank of Montreal
70
Bank of Montreal
Ontario, Canada
$60K -$34.5K -6,883 -39%
T
71
TradeWorx
New Jersey
$58K +$52.9K +10,548 New
PA
72
Profund Advisors
Maryland
$56K +$51.2K +10,200 New
US Bancorp
73
US Bancorp
Minnesota
$55K +$50.2K +10,000 New
LTFS
74
Ladenburg Thalmann Financial Services
Florida
$27K +$8.78K +1,750 +56%
WAM
75
Wolverine Asset Management
Illinois
$17K -$5.02K -1,000 -24%

CHTP Hedge Fund Activity: Q1 2014 in Review

85 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in CHELSEA THERAPEUTICS INT'L LTD (CHTP) for Q1 2014, worth a combined $204M — up 59% from $128M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CHTP positions and 17 closed out — a net gain of 7 holders — while 28 added to existing stakes and 25 trimmed.

The largest buyer was State Street, adding an estimated $15M. The largest seller was VHCP Management, cutting an estimated $4.58M.

  • 85 institutional investors held CHELSEA THERAPEUTICS INT'L LTD (CHTP) as of Q1 2014, up from 78 in Q4 2013.
  • Funds reported $204M of CHELSEA THERAPEUTICS INT'L LTD stock for Q1 2014, up 59% quarter-over-quarter.
  • 24 funds opened new CHELSEA THERAPEUTICS INT'L LTD positions in Q1 2014 and 17 closed out, a net change of +7 holders.
  • The largest CHELSEA THERAPEUTICS INT'L LTD buyer in Q1 2014 was State Street, an estimated $15M added.
  • The largest CHELSEA THERAPEUTICS INT'L LTD seller in Q1 2014 was VHCP Management, an estimated $4.58M sold.

Based on aggregated 13F filings for Q1 2014.